Incontinence-associated dermatitis. Irritant contact dermatitis due to fecal, urinary or dual incontinence
Conditions
Interventions
Intervention 1: Intervention group: Patients receive an acrylate skin protectant. This protectant is made of cyanoacrylate and contains thymoquinone (bioactive compound of Nigella sativa). The duratio
Sponsors
Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with incontinence have either urine or feces, or both.
Exclusion criteria
Exclusion criteria: IAD is limited to those with erythema only, and those with erosions or denudation of the skin are excluded from the study. People with bacterial/fungal infections were excluded from the study. Patients with known allergies to the therapeutic products considered in this study (i.e., zinc oxide or cyanoacrylate) or who showed sensitivity during the intervention period were excluded from the study. Unable to tolerate products for skin cleansing. Those who have ostomy. Having skin problems in the gluteal region, genitals or thighs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin redness (erythema). Timepoint: On day 0 (before intervention) and day 21 (after end of intervention). Method of measurement: Clinician's Erythema Assessment (CEA) scale. (It has grades 0 to 4). | — |
Secondary
| Measure | Time frame |
|---|---|
| Itching/burning at affected skin area. Timepoint: On day 0 (before intervention) and day 21 (after end of intervention). Method of measurement: Numerical rating scale (NRS).;Pain at affected skin area. Timepoint: On day 0 (before intervention) and day 21 (after end of intervention). Method of measurement: Numerical rating scale (NRS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactCyrus Jalili
Kermanshah University of Medical Sciences
Outcome results
None listed